JP2001500149A5 - - Google Patents

Download PDF

Info

Publication number
JP2001500149A5
JP2001500149A5 JP1998513347A JP51334798A JP2001500149A5 JP 2001500149 A5 JP2001500149 A5 JP 2001500149A5 JP 1998513347 A JP1998513347 A JP 1998513347A JP 51334798 A JP51334798 A JP 51334798A JP 2001500149 A5 JP2001500149 A5 JP 2001500149A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998513347A
Other languages
English (en)
Other versions
JP2001500149A (ja
JP4238334B2 (ja
Filing date
Publication date
Priority claimed from GBGB9618899.0A external-priority patent/GB9618899D0/en
Priority claimed from GBGB9713202.1A external-priority patent/GB9713202D0/en
Application filed filed Critical
Priority claimed from PCT/GB1997/002398 external-priority patent/WO1998011063A1/en
Publication of JP2001500149A publication Critical patent/JP2001500149A/ja
Publication of JP2001500149A5 publication Critical patent/JP2001500149A5/ja
Application granted granted Critical
Publication of JP4238334B2 publication Critical patent/JP4238334B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
Figure 2001500149
JP51334798A 1996-09-10 1997-09-08 細胞増殖抑制性ヒドロキサム酸誘導体 Expired - Lifetime JP4238334B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9618899.0 1996-09-10
GBGB9618899.0A GB9618899D0 (en) 1996-09-10 1996-09-10 Cytostatic agents
GB9713202.1 1997-06-24
GBGB9713202.1A GB9713202D0 (en) 1997-06-24 1997-06-24 Cytostatic agents
PCT/GB1997/002398 WO1998011063A1 (en) 1996-09-10 1997-09-08 Cytostatic hydroxamic acid derivatives

Publications (3)

Publication Number Publication Date
JP2001500149A JP2001500149A (ja) 2001-01-09
JP2001500149A5 true JP2001500149A5 (ja) 2005-05-12
JP4238334B2 JP4238334B2 (ja) 2009-03-18

Family

ID=26310010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51334798A Expired - Lifetime JP4238334B2 (ja) 1996-09-10 1997-09-08 細胞増殖抑制性ヒドロキサム酸誘導体

Country Status (16)

Country Link
US (2) US6169075B1 (ja)
EP (1) EP0925278B1 (ja)
JP (1) JP4238334B2 (ja)
CN (1) CN1230175A (ja)
AT (1) ATE220660T1 (ja)
BR (1) BR9712019A (ja)
CA (1) CA2265666C (ja)
CZ (1) CZ298048B6 (ja)
DE (1) DE69714056T2 (ja)
ES (1) ES2181021T3 (ja)
GB (1) GB2324528B (ja)
IL (1) IL128337A0 (ja)
NO (1) NO314227B1 (ja)
NZ (1) NZ333923A (ja)
PL (1) PL191366B1 (ja)
WO (1) WO1998011063A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462023B1 (en) * 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
GB9803005D0 (en) 1998-02-12 1998-04-08 British Biotech Pharm Anti-inflammatory agents
GB9804777D0 (en) * 1998-03-07 1998-04-29 British Biotech Pharm Anti-inflammatory agents
BR9815717A (pt) * 1998-03-12 2000-11-07 British Biotech Pharm Agentes citostáticos
GB9817348D0 (en) * 1998-08-11 1998-10-07 British Biotech Pharm Pharmaceutical use of esters
GB9826153D0 (en) * 1998-11-27 1999-01-20 Hoffmann La Roche Hydrazine derivatives
GB9901863D0 (en) * 1999-01-29 1999-03-17 British Biotech Pharm Antibacterial agents
EP2206712A1 (en) * 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
KR20130111968A (ko) * 2010-06-22 2013-10-11 키에시 파르마슈티시 엣스. 피. 에이. 알칼로이드 아미노에스테르 유도체 및 이의 의약 조성물
US10925851B2 (en) 2018-03-15 2021-02-23 Regents Of The University Of Minnesota Use of Tosedostat and related compounds as analgesics
CN115010850B (zh) * 2022-06-08 2023-09-15 上海大学 具有交联稳定结构的近红外光热聚合物功能材料、其制备方法及其应用

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4599361A (en) 1985-09-10 1986-07-08 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
GB8601368D0 (en) 1986-01-21 1986-02-26 Ici America Inc Hydroxamic acids
FR2609289B1 (fr) 1987-01-06 1991-03-29 Bellon Labor Sa Roger Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes
GB8827308D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
GB8827305D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
GB8919251D0 (en) 1989-08-24 1989-10-04 British Bio Technology Compounds
US5183900A (en) 1990-11-21 1993-02-02 Galardy Richard E Matrix metalloprotease inhibitors
US5270326A (en) 1990-11-21 1993-12-14 University Of Florida Treatment for tissue ulceration
US5239078A (en) 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5892112A (en) * 1990-11-21 1999-04-06 Glycomed Incorporated Process for preparing synthetic matrix metalloprotease inhibitors
DE69108363T2 (de) 1990-12-03 1995-08-31 Celltech Ltd Peptidylderivate.
CA2058797A1 (en) 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
GB9102635D0 (en) 1991-02-07 1991-03-27 British Bio Technology Compounds
GB9107368D0 (en) 1991-04-08 1991-05-22 Smithkline Beecham Plc Novel compounds
CA2102890A1 (en) 1991-05-28 1992-11-29 Soumya P. Sahoo Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
AU2228292A (en) 1991-06-14 1993-01-12 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
US5256657A (en) 1991-08-19 1993-10-26 Sterling Winthrop, Inc. Succinamide derivative matrix-metalloprotease inhibitors
CA2126687A1 (en) 1992-01-15 1993-07-22 Charles G. Caldwell Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
US5525629A (en) 1992-04-07 1996-06-11 British Bio-Technology Limited Inhibition of cytokine production
AU4267293A (en) 1992-05-01 1993-11-29 British Biotech Pharmaceuticals Limited Use of MMP inhibitors
GB9211707D0 (en) 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
GB9211706D0 (en) 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
US5318964A (en) 1992-06-11 1994-06-07 Hoffmann-La Roche Inc. Hydroxamic derivatives and pharmaceutical compositions
AU666727B2 (en) 1992-06-25 1996-02-22 F. Hoffmann-La Roche Ag Hydroxamic acid derivatives
GB9215665D0 (en) 1992-07-23 1992-09-09 British Bio Technology Compounds
AU671724B2 (en) 1993-03-16 1996-09-05 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as metalloproteinase inhibitors
CN1105799A (zh) 1993-03-18 1995-07-26 大制药株式会社 作为基质金属蛋白酶抑制剂的喹诺酮衍生物
GB9307956D0 (en) 1993-04-17 1993-06-02 Walls Alan J Hydroxamic acid derivatives
US5714491A (en) 1993-04-27 1998-02-03 Celltech Therapeutics Limited Peptidyl derivatives as metalloproteinase inhibitors
GB9308695D0 (en) 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
AU7270794A (en) * 1993-08-02 1995-02-28 Celltech Limited Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
CA2168791A1 (en) 1993-08-05 1995-02-16 Arlindo L. Castelhano Matrix metalloprotease inhibitors
NZ271893A (en) 1993-08-23 1997-11-24 Immunex Corp Inhibitors of tnf-alpha secretion
GB9320660D0 (en) 1993-10-07 1993-11-24 British Bio Technology Inhibition of cytokine production
UA48121C2 (uk) 1993-11-04 2002-08-15 Сінтекс (С.Ш.А.) Інк. Інгібітори матричних металопротеаз і фармацетична композиція на їх основі
ES2144819T3 (es) 1994-01-20 2000-06-16 British Biotech Pharm L-terc-leucina-2-piridilamida.
GB9401129D0 (en) 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
CA2181709A1 (en) 1994-01-22 1995-07-27 Raymond Paul Beckett Hydroxamic acid derivatives as metalloproteinase inhibitors
US5514716A (en) 1994-02-25 1996-05-07 Sterling Winthrop, Inc. Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
GB9404046D0 (en) 1994-03-03 1994-04-20 Smithkline Beecham Corp Novel compounds
JPH08114884A (ja) * 1994-08-25 1996-05-07 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5691381A (en) * 1995-04-18 1997-11-25 The Dupont Merck Pharmaceutical Company Hydroxamic and carbocyclic acids as metalloprotease inhibitors
GB9523493D0 (en) 1995-11-16 1996-01-17 British Biotech Pharm Preparation of allyl succinate derivatives and starting materials therefore
NZ322553A (en) 1995-11-23 1998-12-23 British Biotech Pharm Metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2001503856A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2000500076A5 (ja)
JP2000506667A5 (ja)
JP2000503342A5 (ja)
JP2001514785A5 (ja)
JP2000500055A5 (ja)
JP2000500026A5 (ja)
JP2000504992A5 (ja)
JP2000502472A5 (ja)
JP2000500874A5 (ja)
JP2001507069A5 (ja)
JP2000502485A5 (ja)
JP2000501774A5 (ja)
JP2000502425A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000501876A5 (ja)
JP2000501744A5 (ja)
JP2000500857A5 (ja)
JP2000502316A5 (ja)
JP2000502714A5 (ja)
JP2000500318A5 (ja)